MIDATECH PHARMA PLC-ADR (MTP)       0.6728  +0.01 (+1.25%)

0.6728  +0.01 (+1.25%)

US59564R5000 - ADR

MIDATECH PHARMA PLC-ADR0.6728

NASDAQ:MTP (1/30/2023, 12:27:47 PM)+0.01 (+1.25%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS Sector Health Care
GICS Industry Biotechnology

Chartmill FA Rating
Valuation Growth
Profitability Health
Dividend

Overview
Earnings (Last) N/A N/A Earnings (Next) 04-24 2023-04-24
Ins Owners N/A Inst Owners 15.6%
Market Cap 2.92M Shares 4.33M
PE N/A Fwd PE N/A
Dividend Yield N/A Analysts 45.71
IPO 12-08 2014-12-08

Stock Screener Links

Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

MTP Daily chart

Company Profile

Midatech Pharma Plc is a drug delivery technology company. The company is headquartered in Abingdon, Oxfordshire and currently employs 20 full-time employees. The company went IPO on 2014-12-08. The firm is focused on improving the bio-delivery and biodistribution of medicines. The firm's technologies include Q-Sphera, MidaSolve and MidaCore. Q-Sphera technology focusses on long acting injectables using three-dimensional (3D) printing technology. MidaCore technology platform uses ultra-small gold nanoparticle (GNP) drug conjugates. MidaSolve Nano Inclusion technology solubilizes molecules that have minimal solubility at biological potential of Hydrogen (pH) extending available routes of administration, including direct-to-tumor delivery. The company has a pipeline of approximately 10 earlier stage programmes, which includes MTD211 (Schizophrenia, MDD), MTD219 (Prophylaxis, transplant rejection), MTX223, MTX213, MTX214, MTX110 (Glioblastoma), MTX110 (Brain Cancer in Children (DIPG)), MTX110 (Medulloblastoma) and MTX114 (Psoriasis).

Company Info

MIDATECH PHARMA PLC-ADR

Oddfellows Hse, 19 Newport Road

Abingdon OXFORDSHIRE CF24 0AA

P: 4401235888300.0

CEO: Stephen Stamp

Employees: 20

Website: http://www.midatechpharma.com/

MTP News

News Image19 days ago - Bioasis Technologies Inc.Bioasis Technologies Inc. Mails Management Information Circular for Annual and Special Meeting of SecurityholdersNews Imagea month ago - Bioasis Technologies Inc.Bioasis Technologies Inc. Announces Amendments to Arrangement Agreement with Midatech Pharma plcNews Image2 months ago - Bioasis Technologies Inc.Bioasis Technologies Inc. Announces Merger with Midatech Pharma plc

US$10M Registered Direct Offering and PIPE to Strengthen Balance Sheet of Combined Company

MTP Twits

Here you can normally see the latest stock twits on MTP, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example